{'fraction_non_alphanumeric': 0.028846153846153848, 'fraction_numerical': 0.01304945054945055, 'mean_word_length': 5.121848739495798, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Coronavirus (2019-nCoV): Diagnostic approaches, vaccines and ongoing clinical trials.

Background: The new Covid-19 pandemic, first discovered in Wuhan, China, which belongs to the same family of the previous virus that affected the Middle East in 2012 MERS-1, is characterized by its speed of spread and transition which was uncontrolled in the early stages of its appearance. It rapidly affected the whole world and negatively influenced the global healthcare system as well as the international economy. In this article we aimed to present the tests used for the diagnosis of this disease,  trials that are being developed for the synthesis of a vaccine against this pandemic, and also some ongoing clinical trials that are looking at treatments against COVID-19.  Methods: Extensive database searches were performed. The selection of articles was carried out according to the type of study. Results:  Clinical studies gave satisfactory therapeutic results.  COVID-19 vaccines could prevent its transmission and reduce its spread, especially for susceptible populations. Ongoing therapies may have an effective effect in inhibiting or reducing the effects of this virus. Conclusion: research is focused on developing an effective vaccine to sustain immunization over the long term. on the other hand treatments are developed to avoid the complications of the disease.
Keywords: SARS-2, diagnostics, vaccine, clinical trials, MERS-1, treatment, COVID-19.